Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
-
Recce Pharmaceuticals Receives AUD $11.17 Million Research and Development (R&D) Advance
-
S&P upgrades NCL Corporation Ltd.’s credit ratings
-
Stardog Announces Matt Lucas as New Field CTO for Financial Services
-
electroCore to Participate in Upcoming Investor Conferences
-
X4 Pharmaceuticals to Report Fourth-Quarter and Full Year 2023 Financial Results and Host a Conference Call and Webcast on March 21, 2024
-
SIRPant Immunotherapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating SIRPant-M in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
-
Empowering Mothers Everywhere: Momcozy Debuts Its Momcozy Care Program
-
Dalrada Financial Corporation Announces $4.5 Million in Cost-Cutting Reductions to Accelerate Path to Profitability
-
Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types
-
Special Needs Network Secures Over $1 Million in Grant Funding for Groundbreaking Mental Health Initiative
-
Immuneering Appoints Thomas J. Schall, Ph.D. to its Board of Directors
-
Aileron Therapeutics Announces CEO Transition
-
Kratos Unmanned Systems Division Self-Driving Truck Leader Follower Platoon Fleet to Be Deployed in Ohio and Indiana
-
89bio Initiates Phase 3 ENLIGHTEN-Fibrosis Trial of Pegozafermin in Non-Cirrhotic Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Fibrosis
-
NewAmsterdam Pharma Doses First Patient in Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib and Ezetimibe in Patients with HeFH and/or ASCVD
-
Bright Mountain Media's MomLife Panel Empowers Brands with Insights Directly from the Parenting Front Lines
-
Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines
-
Spectral AI Announces New US Government Contract to Further Accelerate the Development of the Handheld Version of DeepView™ Wound Imaging System
-
Shoals Technologies Group Asserts Its Intellectual Property Rights and Vows to Defend Patent
-
The State of Secrets Sprawl 2024
-
TrueCommerce Recognized Again as a Leader in IDC MarketScape: Worldwide Multi-Enterprise Supply Chain Commerce Network
-
TrueCommerce Recognised Again as a Leader in IDC MarketScape: Worldwide Multi-Enterprise Supply Chain Commerce Network
-
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
-
Chatmeter Releases Revolutionary AI Risk Monitoring For Multi-Location Brands
-
Silver Institute Membership Continues to Grow
-
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
Auddia Announces Partnership with Podcast Industry Leader, Sounds Profitable; Provides Update on Enhanced Podcasts
-
Inspired Launches Virtual Sports with Rush Street Interactive on BetRivers in NJ
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
Galectin Therapeutics Expands Clinical Team with the Appointment of Khurram Jamil, M.D. as Vice President, Clinical Development
-
Philips and AWS collaborate to scale digital pathology in the cloud, enhancing diagnostic capabilities and improving productivity
-
Jeffs’ Brands: Since its Acquisition in 2023, Fort has Generated Total Revenues of $5.3 Million From its Amazon Sales
-
QuantGate Systems Inc. Welcomes Robert Séguin to the Board of Directors
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AGEAS - Ordinary Shares
-
Else Nutrition Expands Retail Presence in the United States with Major Midwest Retail Chain
-
Whole Earth Brands Reports Fourth Quarter and Full Year 2023 Results
-
FTI Consulting Names Jiva Jagtap as Global Leader of Private Equity
-
All Major Equipment Received for HPQ Fumed Silica Reactor Pilot Plant
-
Sintana Energy Announces Results of Warrant Exercise Activity – Approximately 99% Exercise Rate Generating $22.5MM in Additional Cash Resources
-
Immunovant Awarded U.S. Patent for IMVT-1402
-
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
-
Cartier cuts 13.2 g/t Au over 2.3 m in the VG Zone of the Chimo Mine Project
-
Metasphere Labs and Bluesphere Ventures Unveil Research Paper on Leveraging Bitcoin, AI, and the Metaverse for Sustainability
-
CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Fireweed Upgrades to Trade Shares on the OTCQX Best Market
-
Southern California Clinic uses MedMatrix AI Market Expander to Launch Opening of New Clinic Locations
-
A Bigger Dispensary Opens in the Town of “Big Things” as MariMed Opens Larger, Permanent Thrive Dispensary in Casey, Illinois
-
Dorman new releases for March include dozens of cost-saving repair solutions and aftermarket-exclusive innovations
-
Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis
